Activation of both NLRP3 inflammasome and caspase-11 inflammasome lead to the secretion of potent proinflammatory cytokines, IL-1beta and IL-18 [66], which are well recognized as potential therapeutic targets for acute myocardial infarction [67,68,69]. This evidence concerns the gene NLRP3 and acute myocardial infarction.